TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -5.14%23.48B | ---- | 0.51%37.36B | ---- | -6.68%24.75B | ---- | 4.41%37.17B | ---- | -8.37%26.52B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 4.68%-28.4B | ---- | -4.80%-59.16B | ---- | -6.99%-29.79B | ---- | 3.56%-56.45B | ---- | 7.25%-27.84B |
Interest expense - adjustment | ---- | 11.92%9.53B | ---- | -16.48%17.13B | ---- | -18.09%8.52B | ---- | -13.73%20.5B | ---- | -21.43%10.4B |
Impairment and provisions: | ---- | -9.95%20.66B | ---- | -4.49%47.23B | ---- | -5.47%22.94B | ---- | -37.23%49.45B | ---- | -34.48%24.27B |
-Other impairments and provisions | ---- | -9.95%20.66B | ---- | -4.49%47.23B | ---- | -5.47%22.94B | ---- | -37.23%49.45B | ---- | -34.48%24.27B |
Revaluation surplus: | ---- | 83.59%4.43B | ---- | -66.30%2.73B | ---- | 42.95%2.41B | ---- | 449.52%8.09B | ---- | 178.84%1.69B |
-Other fair value changes | ---- | 83.59%4.43B | ---- | -66.30%2.73B | ---- | 42.95%2.41B | ---- | 449.52%8.09B | ---- | 178.84%1.69B |
Asset sale loss (gain): | ---- | -10.45%-5.39B | ---- | 7.31%-9.11B | ---- | -20.63%-4.88B | ---- | -12.05%-9.83B | ---- | 7.35%-4.05B |
-Loss (gain) on sale of property, machinery and equipment | ---- | -1,267.86%-327M | ---- | 58.87%-51M | ---- | 136.36%28M | ---- | -1,227.27%-124M | ---- | 61.11%-77M |
-Loss (gain) from selling other assets | ---- | -3.16%-5.07B | ---- | 6.65%-9.06B | ---- | -23.68%-4.91B | ---- | -10.50%-9.71B | ---- | 4.80%-3.97B |
Depreciation and amortization: | ---- | 6.24%4.4B | ---- | 6.52%8.31B | ---- | 9.85%4.14B | ---- | 5.37%7.81B | ---- | 4.70%3.77B |
-Depreciation | ---- | 6.24%4.4B | ---- | 6.52%8.31B | ---- | 9.85%4.14B | ---- | 5.37%7.81B | ---- | 4.70%3.77B |
Operating profit before the change of operating capital | ---- | 2.22%28.7B | ---- | -21.60%44.48B | ---- | -19.19%28.08B | ---- | -28.83%56.74B | ---- | -24.93%34.75B |
Change of operating capital | ||||||||||
Buy and sell back financial assets (increase) decrease | ---- | 308.21%14.61B | ---- | -1,885.87%-32.75B | ---- | 37.23%-7.02B | ---- | -108.21%-1.65B | ---- | -190.47%-11.18B |
Loans and payments (increase) decrese | ---- | 78.94%-55.97B | ---- | -95.92%-283.41B | ---- | -43.36%-265.77B | ---- | 40.90%-144.66B | ---- | 6.88%-185.39B |
Special items of changes in operating assets | ---- | 164.19%19.51B | ---- | 74.22%-20.66B | ---- | 44.03%-30.39B | ---- | -553.33%-80.15B | ---- | -172.16%-54.29B |
Borrowing from the central bank increase (decrese) | ---- | -187.54%-31.32B | ---- | 235.29%180.43B | ---- | 240.97%35.78B | ---- | -958.05%-133.37B | ---- | -369.32%-25.38B |
Customer's deposits increase (decrese) | ---- | -188.04%-218.27B | ---- | 32.93%289.48B | ---- | -26.62%247.93B | ---- | 357.62%217.77B | ---- | 172.11%337.87B |
Special items for changes in operating liabilities | ---- | -215.78%-59.63B | ---- | 29.05%87B | ---- | 222.80%51.5B | ---- | --67.42B | ---- | --15.95B |
Cash from business operations | ---- | -602.98%-302.36B | ---- | 1,577.36%264.57B | ---- | -46.49%60.11B | ---- | 80.60%-17.91B | ---- | 64.31%112.34B |
Other taxs | ---- | 19.83%-2.68B | ---- | 50.02%-4.6B | ---- | 56.45%-3.34B | ---- | 29.04%-9.21B | ---- | 37.57%-7.68B |
Special items of business | ---- | -59.12%21.2B | ---- | -196.33%-186.29B | ---- | 328.05%51.86B | ---- | -25.82%193.39B | ---- | -109.81%-22.74B |
Adjustment items of business operations | -257.52%-194.6B | ---- | -156.36%-127.37B | ---- | 1,059.29%123.54B | ---- | 58.91%225.97B | ---- | -104.34%-12.88B | ---- |
Net cash from operations | -257.52%-194.6B | -361.29%-283.84B | -156.36%-127.37B | -55.69%73.68B | 1,059.29%123.54B | 32.60%108.63B | 58.91%225.97B | 6.99%166.27B | -104.34%-12.88B | -71.55%81.92B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | 0.06%44.87B | ---- | 31.94%13.22B | ---- | -14.58%44.84B | ---- | -47.09%10.02B | ---- | 17.54%52.49B | ---- |
Sale of fixed assets | 147.42%3.12B | 108.91%1.92B | -80.50%209M | -29.70%2.16B | -56.47%1.26B | -59.60%920M | -1.02%1.07B | 9.29%3.07B | -55.46%2.89B | 1.24%2.28B |
Purchase of fixed assets | 6.63%-5.53B | -28.51%-4.36B | -204.63%-7.64B | 19.00%-8.68B | 37.93%-5.93B | 58.79%-3.39B | -95.25%-2.51B | -13.17%-10.71B | -3.26%-9.55B | -132.06%-8.23B |
Recovery of cash from investments | 32.60%1.4T | 36.41%1.14T | 16.93%394.97B | 38.87%1.44T | 51.27%1.06T | 40.74%833.13B | 15.91%337.8B | -23.50%1.04T | -27.42%700.18B | -9.29%591.95B |
Cash on investment | -31.55%-1.44T | -31.96%-1.1T | 1.44%-389.53B | -21.88%-1.39T | -28.05%-1.1T | -18.31%-833.35B | -19.25%-395.21B | 7.22%-1.14T | 2.63%-856.34B | -27.64%-704.36B |
Net cash from investment operations | 56.55%4.34B | 1,375.86%34.36B | 123.02%11.24B | 137.18%41.76B | 102.51%2.77B | 97.72%-2.69B | -129.93%-48.83B | -195.27%-112.33B | -186.77%-110.32B | -219.04%-118.37B |
Net cash before financing | -250.64%-190.27B | -335.50%-249.48B | -165.55%-116.12B | 113.99%115.44B | 202.53%126.31B | 390.65%105.94B | 46.44%177.14B | -80.26%53.95B | -129.06%-123.19B | -109.41%-36.45B |
Cash flow from financing activities | ||||||||||
Refund | -41.16%-833.66B | -14.33%-606.38B | 6.97%-262.59B | -9.03%-992.77B | -3.62%-590.58B | -41.70%-530.38B | -18.29%-282.27B | ---910.53B | 36.48%-569.93B | ---374.29B |
Issuance of bonds | 76.49%997.27B | 54.18%780.55B | 69.12%291.08B | 22.04%1.02T | -7.78%565.05B | 20.46%506.25B | -19.19%172.12B | 9.18%836.97B | 17.92%612.72B | 37.17%420.26B |
Interest paid - financing | ---- | 0.00%-3.44B | ---- | -6.50%-3.44B | ---- | 58.98%-3.44B | ---- | 77.03%-3.23B | ---- | -11.83%-8.39B |
Dividends paid - financing | 22.02%-11.93B | 66.64%-4.01B | 21.90%-1.91B | -39.22%-28.73B | -4.94%-15.3B | -56.60%-12.03B | 2.24%-2.45B | -92.21%-20.64B | 16.74%-14.58B | -1.33%-7.68B |
Issuance expenses and redemption of securities expenses | ---- | -100.00%-6M | ---- | 90.32%-9M | ---- | 97.78%-3M | ---- | 99.99%-93M | ---- | 99.98%-135M |
Other items of the financing business | -159.52%-16.08B | -2,188.91%-41.7B | 23.18%-802M | -390.05%-3.79B | -517.75%-6.2B | -157.95%-1.82B | -16.00%-1.04B | -94.99%1.31B | -103.68%-1B | -88.86%3.14B |
Net cash from financing operations | 388.29%135.59B | 401.82%125.01B | 122.68%25.78B | 92.45%-7.26B | -272.90%-47.03B | -225.85%-41.42B | -291.29%-113.64B | 63.93%-96.21B | 107.40%27.2B | 113.09%32.91B |
Effect of rate | -60.69%478M | -89.00%181M | 268.22%937M | -88.09%851M | -85.65%1.22B | -41.98%1.65B | -35.52%-557M | 746.11%7.15B | 1,710.84%8.47B | 388.90%2.84B |
Net Cash | -168.97%-54.67B | -292.93%-124.48B | -242.28%-90.35B | 355.99%108.18B | 182.58%79.27B | 1,923.66%64.52B | -30.92%63.5B | -739.80%-42.26B | -271.34%-95.99B | -102.60%-3.54B |
Begining period cash | 84.98%237.34B | 84.98%237.34B | 84.98%237.34B | -21.49%128.31B | -21.49%128.31B | -21.49%128.31B | -21.49%128.31B | 3.48%163.42B | 3.48%163.42B | 3.48%163.42B |
Cash at the end | -12.29%183.14B | -41.87%113.04B | -22.65%147.93B | 84.98%237.34B | 175.09%208.79B | 19.52%194.47B | -24.98%191.25B | -21.49%128.31B | -64.44%75.9B | -44.44%162.72B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.